Snehal has a breadth of knowledge and experience in leading roles in Technical Operations including Manufacturing, Technology, and Quality Assurance in Biologics, Small Molecules, and most recently in Cell Therapy. He is routinely sought out for his technical operational expertise, as well as his ability to collaborate and influence across all levels of the organization. In previous roles, Snehal has led a growing global manufacturing network to produce Clinical and Commercial Cell Therapy Products, including two cell therapies recently commercially launched in 2021. Prior to this role he was a Site Head for Cell Therapy Manufacturing. Earlier in his career, he held a variety of different roles with increasing responsibility, including Head of Global External Drug Product Manufacturing, Head of Drug Product Operations, and Head of Quality Operations.
Track Chair: Sharon Benzeno, Adaptive Biotechnologies